Abstract:Background Cryptococcal meningitis is a leading cause of adult community-acquired meningitis in sub-Saharan Africa with high mortality rates in the first 10 weeks post diagnosis. Practical tools to stratify mortality risk may help to tailor effective treatment strategies. Methods We pooled individual-level data from two randomised-controlled trials of HIV-associated cryptococcal meningitis across eight sub-Saharan African countries (ACTA, ; Ambition-cm, ). We used this pooled dataset to develop and validate multivariable logistic regression models for 2-week and 10-week mortality. Candidate predictor variables were specified a priori. Basic models were developed using only predictors available in resource-limited settings; Research models were developed from all available predictors. We used internal-external cross-validation to evaluate performance across countries within the development cohort, before validation of discrimination, calibration and net benefit in held-out data from Malawi (Ambition-cm trial). We also evaluated whether treatment effects in the trials were heterogenous by predicted mortality risk. Findings We included 1488 participants, of whom 236 (15.9%) and 469 (31.5%) met the 2-week and 10-week mortality outcomes, respectively. In the development cohort (n=1263), five variables were selected into the basic model (haemoglobin, neutrophil count, Eastern Cooperative Oncology Group performance status, Glasgow coma scale and treatment regimen), with two additional variables in the research model (cerebrospinal fluid quantitative culture and opening pressure) for 2-week mortality. During internal-external cross-validation, both models showed consistent discrimination across countries (pooled areas under the receiver operating characteristic curves (AUROCs) 0.75 (95% CI 0.68-0.82) and 0.78 (0.75-0.82) for the Basic and Research 2-week mortality models, respectively), with some variation in calibration between sites. Performance was similar in held-out validation (n=225), with the models demonstrating higher net benefit to inform decision-making than alternative approaches including a pre-existing comparator model. In exploratory analyses, treatment effects varied by predicted mortality risk, with a trend towards lower absolute and relative mortality for a single high-dose liposomal Amphotericin B-based regimen (in comparison to 1-week Amphotericin B deoxycholate plus flucytosine) among lower risk participants in the Ambition-cm trial. Interpretation Both models accurately predict mortality, were generalisable across African trial settings, and have potential to be incorporated into future treatment stratification approaches in low and middle-income settings. Funding: MRC, United Kingdom (100504); ANRS, France (ANRS12275); SIDA, Sweden (TRIA2015-1092); Wellcome/MRC/UKAID Joint Global Health Trials (MR/P006922/1); European DCCT Partnership; NIHR, United Kingdom through a Global Health Research Professorship to JNJ (RP-2017-08-ST2-012) and a personal Fellowship to RKG (NIHR302829).

Biomarkers of mortality in adults and adolescents with advanced HIV in sub-Saharan Africa

Plasma IL-6/IL-10 Ratio and IL-8, LDH, and HBDH Level Predict the Severity and the Risk of Death in AIDS Patients with Pneumocystis Pneumonia.

Increased Microbial Translocation is a Prognostic Biomarker of Different Immune Responses to ART in People Living with HIV

The association of antibody immunity with cryptococcal antigenemia and mortality in a South African cohort with advanced HIV disease

Early inflammation as a footprint of increased mortality risk in infants living with HIV from three African countries

Gut Epithelial Barrier Dysfunction and Innate Immune Activation Predict Mortality in Treated HIV Infection

Novel Biomarkers of Cardiac Stress, Cardiovascular Dysfunction, and Outcomes in HIV-Infected Individuals

Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study

CSF Cytokines and Chemokines Involved in Cytotoxic Cell Function and Risk of Acute 14-Day Mortality in Persons with Advanced HIV and Cryptococcal Meningitis

Immunologic and vascular biomarkers of mortality in critical COVID-19 in a South African cohort

Soluble Urokinase Plasminogen Activator Receptor Is Predictive of Non-AIDS Events During Antiretroviral Therapy-mediated Viral Suppression

Differential effects of antiretroviral treatment on immunity and gut microbiome composition in people living with HIV in rural versus urban Zimbabwe

Autopsy Prevalence of Tuberculosis and Other Potentially Treatable Infections among Adults with Advanced HIV Enrolled in Out-Patient Care in South Africa

Predicting mortality within 1 year of ART initiation in children and adolescents living with HIV in sub-Saharan Africa: a retrospective observational cohort study

Mortality and Its Predictors among Adult Human Immune-Deficiency Virus-Infected Patients Attending Their Antiretroviral Treatment at Health Centers, Addis Ababa, Ethiopia: Multicenter Retrospective Cohort Study

Mid–Upper Arm Circumference Is a Strong Predictor of Mortality Among Ugandan Adults With HIV-Associated Cryptococcal Meningitis: A Prospective Cohort Study

High mortality following early initiation of antiretroviral therapy in infants living with HIV from three African countries

Mortality and associated risk factors among people living with HIV with Kaposi sarcoma: A5263/AMC066 and A5264/AMC067

Personalised risk prediction tools for cryptococcal meningitis mortality to guide treatment stratification; a pooled analysis of two randomised-controlled trials

Baseline C-reactive Protein as a Risk Factor for Cryptococcal Meningitis and Death in HIV-associated Cryptococcal Antigenemia With CrAg Titer as an Effect Modifier

Survival and predictors of mortality among HIV-infected adults after initiation of antiretroviral therapy in Eastern Ethiopia Governmental hospitals, from January 2015 to December 2021 (multi-center retrospective follow-up study)